Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease

Fig. 5

Liver fibrosis decision curve analysis. Decision curve analysis depict the clinical net benefit. NomogramS3S4 is compared with APRI, FIB-4, and GPR for predicting advanced fibrosis in the training set (a); NomogramS4 is compared with APRI, FIB-4, and GPR for predicting cirrhosis in the validation set (b); NomogramS3S4 is compared with APRI, FIB-4, and GPR for predicting advanced fibrosis in the training set (c); NomogramS4 is compared with APRI, FIB-4, and GPR for predicting cirrhosis in the validation set (d). Black line = net benefit when no patient will experience the event; gray line = net benefit when all patients will experience the event. The preferred markers is the marker with the highest net benefit at any given threshold

Back to article page